A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling

Beghini, 2001, Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa, Cancer., 92, 657, 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D

Benson, 2006, Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K, Eur. J. Immunol., 36, 2535, 10.1002/eji.200535483

Bishop, 2004, The multifaceted roles of TRAFs in the regulation of B-cell function, Nat. Rev. Immunol., 4, 775, 10.1038/nri1462

Briones, 2002, BLyS and BLyS receptor expression in non-Hodgkin’s lymphoma, Exp. Hematol., 30, 135, 10.1016/S0301-472X(01)00774-3

Castigli, 2005, TACI and BAFF-R mediate isotype switching in B cells, J. Exp. Med., 201, 35, 10.1084/jem.20032000

Cerhan, 2007, Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma, Blood., 110, 4455, 10.1182/blood-2007-05-088682

Chompret, 2004, PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor, Gastroenterology., 126, 318, 10.1053/j.gastro.2003.10.079

Davis, 2010, Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma, Nature., 463, 88, 10.1038/nature08638

Fu, 2006, Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas, Blood., 107, 4540, 10.1182/blood-2005-10-4042

Gross, 2000, TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease, Nature., 404, 995, 10.1038/35010115

Gross, 2001, TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS, Immunity., 15, 289, 10.1016/S1074-7613(01)00183-2

Gulmann, 2005, Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma, Clin. Cancer Res., 11, 5847, 10.1158/1078-0432.CCR-05-0637

Gupta, 2009, Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2, Blood., 114, 2926, 10.1182/blood-2009-05-220889

Hancz, 2008, Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95), Immunol. Lett., 116, 211, 10.1016/j.imlet.2007.12.009

Hatzoglou, 2000, TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase, J. Immunol., 165, 1322, 10.4049/jimmunol.165.3.1322

Haxhinasto, 2002, Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction, J. Immunol., 169, 1145, 10.4049/jimmunol.169.3.1145

He, 2003, EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching, J. Immunol., 171, 5215, 10.4049/jimmunol.171.10.5215

He, 2004, Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL, J. Immunol., 172, 3268, 10.4049/jimmunol.172.5.3268

Hostager, 2003, Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling, J. Biol. Chem., 278, 45382, 10.1074/jbc.M306708200

Hsing, 1999, Requirement for nuclear factor-kappaB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes, J. Immunol., 162, 2804, 10.4049/jimmunol.162.5.2804

Khare, 2000, Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice, Proc. Natl. Acad. Sci. USA., 97, 3370, 10.1073/pnas.050580697

Kobayashi, 2009, TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses, PLoS One., 4, e4736, 10.1371/journal.pone.0004736

Lamothe, 2007, Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation, J. Biol. Chem., 282, 4102, 10.1074/jbc.M609503200

Larkin, 2007, Clustal W and Clustal X version 2.0, Bioinformatics., 23, 2947, 10.1093/bioinformatics/btm404

Leich, 2009, Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations, Blood., 114, 826, 10.1182/blood-2009-01-198580

Lenz, 2008, Oncogenic CARD11 mutations in human diffuse large B cell lymphoma, Science., 319, 1676, 10.1126/science.1153629

Liu, 2009, Act1, a U-box E3 ubiquitin ligase for IL-17 signaling, Sci. Signal., 2, ra63, 10.1126/scisignal.2000382

Losi, 2005, Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency, J. Clin. Immunol., 25, 496, 10.1007/s10875-005-5637-2

Mackay, 1999, Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations, J. Exp. Med., 190, 1697, 10.1084/jem.190.11.1697

Madry, 1998, The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily, Int. Immunol., 10, 1693, 10.1093/intimm/10.11.1693

Moore, 2005, Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes, J. Immunol., 175, 3780, 10.4049/jimmunol.175.6.3780

Moore, 1999, BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator, Science., 285, 260, 10.1126/science.285.5425.260

Morrison, 2005, An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway, J. Biol. Chem., 280, 10018, 10.1074/jbc.M413634200

Mukhopadhyay, 1999, Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase, J. Biol. Chem., 274, 15978, 10.1074/jbc.274.23.15978

Ni, 2004, Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation, J. Immunol., 173, 7394, 10.4049/jimmunol.173.12.7394

Novak, 2004, Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome, Blood., 104, 2247, 10.1182/blood-2004-02-0762

Novak, 2006, Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders, J. Clin. Oncol., 24, 983, 10.1200/JCO.2005.02.7938

Novak, 2009, Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma, Cancer Res., 69, 4217, 10.1158/0008-5472.CAN-08-4915

Otipoby, 2008, BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells, Proc. Natl. Acad. Sci. USA., 105, 12435, 10.1073/pnas.0805460105

Qian, 2004, Act1, a negative regulator in CD40- and BAFF-mediated B cell survival, Immunity., 21, 575, 10.1016/j.immuni.2004.09.001

Rowland, 2007, A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling, J. Immunol., 179, 4645, 10.4049/jimmunol.179.7.4645

Salzer, 2005, Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans, Nat. Genet., 37, 820, 10.1038/ng1600

Salzer, 2009, Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes, Blood., 113, 1967, 10.1182/blood-2008-02-141937

Schiemann, 2001, An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway, Science., 293, 2111, 10.1126/science.1061964

Schneider, 1999, BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth, J. Exp. Med., 189, 1747, 10.1084/jem.189.11.1747

Schneider, 2001, Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen, J. Exp. Med., 194, 1691, 10.1084/jem.194.11.1691

Shu, 1999, TALL-1 is a novel member of the TNF family that is down-regulated by mitogens, J. Leukoc. Biol., 65, 680, 10.1002/jlb.65.5.680

Thompson, 2000, BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population, J. Exp. Med., 192, 129, 10.1084/jem.192.1.129

Thompson, 2001, BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF, Science., 293, 2108, 10.1126/science.1061965

Vallabhapurapu, 2009, Regulation and function of NF-kappaB transcription factors in the immune system, Annu. Rev. Immunol., 27, 693, 10.1146/annurev.immunol.021908.132641

Vallabhapurapu, 2008, Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling, Nat. Immunol., 9, 1364, 10.1038/ni.1678

von Bülow, 1997, NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily, Science., 278, 138, 10.1126/science.278.5335.138

von Bülow, 2000, Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse, Mamm. Genome., 11, 628, 10.1007/s003350010125

Xia, 2000, TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation, J. Exp. Med., 192, 137, 10.1084/jem.192.1.137

Yan, 2001, Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency, Curr. Biol., 11, 1547, 10.1016/S0960-9822(01)00481-X

Zarnegar, 2008, Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK, Nat. Immunol., 9, 1371, 10.1038/ni.1676